Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
COAL TAR
Ego Pharmaceuticals (UK) Limited
2.30 %w/w
Cutaneous Solution
2000-02-04
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0863/006/001 Case No: 2038246 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to EGO PHARMACEUTICALS (UK) LIMITED 15 WINDSOR PARK, 50 WINDSOR AVENUE, MERTON, LONDON SW19 2TJ, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations, in respect of the product PINETARSOL CUTANEOUS SOLUTION The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 07/08/2007 until 03/02/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 22/09/2007_ _CRN 2038246_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pinetarsol Cutaneous Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Tar 2.3% w/w. For excipients, see 6.1. 3 PHARMACEUTICAL FORM Cutaneous solution Aqua blue/green, sudsing, solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As an adjunct in the management of psoriasis and chronic forms of dermatitis and eczema. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Pinetarsol Solution is intended for addition to water or for use on wet skin as follows: Bath: Add 15 - 30 ml to a warm to tepid bath (5 ml to a baby's bath or hand basin). Bathe for 5 to 10 minutes Read the complete document